MedTrace Logo

Rhythmic Auditory Stimulation and Dual-task Gait Training in Chronic Stroke

NCT07709130 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 46

Last updated 2026-07-16

No results posted yet for this study

Summary

Rhythmic auditory stimulation and dual-task gait training may improve post-stroke mobility, but evidence regarding integrated programmes and age-related differences in treatment response remains limited. The aim of the study is to evaluate changes in mobility, balance, motor dual-task performance, concern about falling, and health-related quality of life after a six-week combined programme, and to explore whether responses differed across age strata.

Conditions

  • Stroke
  • Dual Task
  • Gait Training
  • Auditory Task

Interventions

OTHER

Rhythmic Auditory Stimulation and Motor Dual-Task Gait Training Programme

The intervention combined RAS with progressively intensified motor dual-task gait training.6 Participants completed a supervised six-week programme comprising three 30-minute sessions per week (18 sessions; planned dose, 540 minutes). During each session, they synchronized their steps with a metronome while performing tandem walking with progressively demanding object-carrying tasks. Participants maintained their usual walking speed and were instructed to give equal attention to gait and the concurrent motor task. Progression was designed by the research team in accordance with general motor-learning principles and involved predefined weekly increases in metronome tempo and concurrent motor-task complexity. provided that the preceding stage had been completed safely. All sessions were delivered individually by the same licensed physiotherapist experienced in neurology.

Sponsors & Collaborators

  • İstanbul Yeni Yüzyıl Üniversitesi

    collaborator OTHER

  • Recep Tayyip Erdogan University

    lead OTHER

Study Design

Allocation
NA
Purpose
HEALTH_SERVICES_RESEARCH
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Max Age
72 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2026-01-15
Primary Completion
2026-05-15
Completion
2026-05-15

Countries

  • Turkey (Türkiye)

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07709130 on ClinicalTrials.gov